Jul 6, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Clues About Protection From HIV From Follow-Up Studies To The RV144 HIV Vaccine Trial
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2686116" data-attributes="member: 124445"><p>Researchers have gained important clues about immune system responses that could play a role in protecting people from HIV infection in follow-up studies from the world's largest HIV vaccine trial to date. Results from laboratory studies based on the trial were published in the New England Journal of Medicine. The HIV vaccine trial in Thailand, called RV144, showed that the group receiving the vaccine regimen was estimated to be 31.2 percent less likely to be infected than those who didn't get the vaccine, and researchers set out to learn why...<img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/Y1E1pna2w9I" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/Y1E1pna2w9I/243792.php" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2686116, member: 124445"] Researchers have gained important clues about immune system responses that could play a role in protecting people from HIV infection in follow-up studies from the world's largest HIV vaccine trial to date. Results from laboratory studies based on the trial were published in the New England Journal of Medicine. The HIV vaccine trial in Thailand, called RV144, showed that the group receiving the vaccine regimen was estimated to be 31.2 percent less likely to be infected than those who didn't get the vaccine, and researchers set out to learn why...[IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/Y1E1pna2w9I[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/Y1E1pna2w9I/243792.php]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top